NasdaqGS - Delayed Quote • USD
Sotera Health Company (SHC)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 4:20 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 7 | 7 |
| Avg. Estimate | 0.13 | 0.18 | 0.71 | 0.85 |
| Low Estimate | 0.11 | 0.16 | 0.7 | 0.82 |
| High Estimate | 0.15 | 0.2 | 0.72 | 0.93 |
| Year Ago EPS | 0.13 | 0.21 | 0.81 | 0.71 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 7 | 7 |
| Avg. Estimate | 244.56M | 276.65M | 1.1B | 1.18B |
| Low Estimate | 234.8M | 265.71M | 1.1B | 1.17B |
| High Estimate | 255M | 286.9M | 1.11B | 1.19B |
| Year Ago Sales | 220.59M | 255.28M | 1.05B | 1.1B |
| Sales Growth (year/est) | 10.90% | 8.40% | 4.90% | 7.10% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | 0.14 | 0.17 | 0.2 | 0.26 |
| EPS Actual | 0.13 | 0.21 | 0.21 | 0.26 |
| Difference | -0.01 | 0.04 | 0.01 | 0 |
| Surprise % | -7.10% | 23.50% | 5.00% | 0.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.13 | 0.18 | 0.71 | 0.85 |
| 7 Days Ago | 0.13 | 0.18 | 0.71 | 0.85 |
| 30 Days Ago | 0.13 | 0.18 | 0.71 | 0.85 |
| 60 Days Ago | 0.15 | 0.2 | 0.8 | 0.95 |
| 90 Days Ago | 0.19 | 0.23 | 0.88 | 1.02 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | 1 | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | SHC | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 0.00% | -- | -- | 6.50% |
| Next Qtr. | -14.30% | -- | -- | 12.00% |
| Current Year | -12.30% | -- | -- | 5.30% |
| Next Year | 19.70% | -- | -- | 13.10% |
| Next 5 Years (per annum) | 12.00% | -- | -- | 11.09% |
| Past 5 Years (per annum) | 11.75% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | Barclays: Overweight to Overweight | 4/10/2024 |
| Upgrade | Citigroup: Neutral to Buy | 4/3/2024 |
| Upgrade | Jefferies: Hold to Buy | 3/25/2024 |
| Reiterates | RBC Capital: Outperform to Outperform | 3/11/2024 |
| Reiterates | RBC Capital: Outperform to Outperform | 3/4/2024 |
| Maintains | Barclays: Overweight to Overweight | 2/28/2024 |
Related Tickers
QGEN Qiagen N.V.
41.65
+1.39%
NEOG Neogen Corporation
12.14
+1.51%
THOXF BioPorto A/S
0.3100
0.00%
SEQL SeqLL Inc.
1.3000
0.00%
BIAFW bioAffinity Technologies, Inc.
0.4500
+12.50%
0RUG.IL bioMérieux S.A.
100.94
+1.70%
CDNA CareDx, Inc
7.56
0.00%
TELO.V Telo Genomics Corp.
0.1700
-5.56%
XGN Exagen Inc.
1.4121
+0.86%
PMD Psychemedics Corporation
2.5500
-2.67%